According to preclinical and clinical trials, it is generally considered to promote tumour growth; however, there is no unanimity, as Pircher et al. [39] (2018) proved that insulin might suppress the activation of mTOR and inhibit tumour growth. This evidence concerns the gene INS and neoplasm.